「血管内手術の現状と今後の展望」 脳血管内治療の現況
スポンサーリンク
概要
- 論文の詳細を見る
Clinical application of neuro-endovascular therapy was first reported in 1974 by Servineko et al., who used a detachable balloon to treat a symptomatic carotid cavernous fistula. The fistula was occluded by the detachable balloon and the patient′s symptoms improved. Embolization of aneurysms was greatly advanced by the introduction of the Guglielmi detachable coil, and since then, remarkable progress has been achieved in endovascular treatment of aneurysms. Verification of the efficacy of neuro-endovascular therapy for ruptured aneurysms, such as coil embolization for intracranial aneurysms, has been demonstrated by the International Subarachnoid Aneurysm Trial (ISAT). ISAT results indicate the vital role played by this therapy in improving the treatment of subarachnoid hemorrhage. Recently, new instruments for neuro-endovascular therapy have been approved for clinical use in Japan. These instruments include vascular reconstruction devices (VRD) such as the Enterprise self-expanding stent system for unruptured wide-neck aneurysms larger than 7 mm, Onyx (ethylene vinyl alcohol) liquid material for embolization of arteriovenous malformations, and the Merci retriever for mechanical removal of emboli in acute stroke within 8 hours of onset. Furthermore, innovative diagnostic modalities, such as flat panel detectors and three-dimensional digital subtraction angiography (3D-DSA) have contributed to both the development and safety of neuro-endovascular therapy. Advances in device and diagnostic technology have made it possible to treat even difficult cases. This review summarizes current neuro-endovascular treatment for neurosurgical diseases.
- 日本大学医学会の論文
日本大学医学会 | 論文
- SSPE麻疹ウイルスによる細胞融合能機能解析
- 閉塞性動脈硬化症例おける血管内皮前駆細胞の動態
- 下肢静脈瘤に対する術式の相違による神経障害の検討
- Paclitaxel と Trastuzmab の併用療法が長期間奏効した再発進行乳癌の2例
- 日大外科の手術力 : 2007年度外科学系手術統計